E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

  • Law Blogs

Become a Fan

« Top NIH-funded U.S. Universities 2014 | Main | Webinar on Patents and Export Control Compliance »

August 21, 2014

Comments

Don,

I'm a member of the Policy Advisory Committee for AUTM who reviewed and made suggestions to the AUTM et al. comments letter. I can tell that university TTOs consider these Myriad-Mayo Guidelines as being very problematical on many levels for academic research generally, and tech transfer specifically.

Don,

My apologies, I should have said I was a member of the Public Policy Advisory Committee for AUTM.

what is it is not even clear that the "product of nature" actually occurs as such in nature? EG, cultured cells? Guidelines don't even address that.

The comments to this entry are closed.

November 2014

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30